The abstract is read at the publisher; the summary is JClub's.
The Exerkine Atlas compiles 35 exercise-linked exerkines, showing only four have clear clinical validation and nine more have reached clinical testing or late preclinical development.
- Why it matters: The field lacks a unified view of which exerkines are therapeutically ready and how context-dependent effects, delivery constraints, and network dynamics complicate translation.
- What they did: The authors evaluated 34 exerkines plus IC7Fc, classifying each by translational readiness and primary clinical domain, then synthesized cross-molecule challenges.
- The result: The resource supports biomarker and therapeutic-discovery strategies by integrating curated literature and clinical trial data in an open-access web platform.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.